Fixed Lingual Mandibular Growth Modificator
A Prospective Controlled Evaluation of Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM)
Sponsor: Damascus University
A NA clinical study on Class II Division 1 Malocclusion and Retrognathic Mandible, this trial is completed. The trial is conducted by Damascus University and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Phase: PHASE2 → NA
▶ Show 2 earlier versions
-
Feb 2017 — Dec 2020 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Damascus University
For direct contact, visit the study record on ClinicalTrials.gov .